Astacidin PcAst-2

General Information


DRACP ID  DRACP00938

Peptide Name   Astacidin PcAst-2

Sequence  FYPRPYRPPYLPDPRPFPRPLPAFGHEFRRH

Sequence Length  31

UniProt ID  Not available

PubChem CID  Not available

Origin  Procambarus clarkii

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MEC-1 Chronic lymphocytic leukemia; B-cell chronic lymphocytic leukemia Leukemia Not active up to 100 µM MTT assay 24h 1
T24 Bladder carcinoma Carcinoma IC50>100 µM MTT assay 24h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00938

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C187H263N53O39

Absent amino acids  CIKMNQSTVW

Common amino acids  P

Mass  441270

Pl  11.14

Basic residues  8

Acidic residues  2

Hydrophobic residues  7

Net charge  6

Boman Index  -9028

Hydrophobicity  -129.35

Aliphatic Index  28.39

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  4470

Absorbance 280nm  149

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31884202

Title  Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852)

Doi 10.1016/j.dci.2019.103574

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.